{"id":231,"date":"2015-02-05T07:41:25","date_gmt":"2015-02-05T12:41:25","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=231"},"modified":"2015-02-05T08:59:42","modified_gmt":"2015-02-05T13:59:42","slug":"ipo-pricings-2-4-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pricings-2-4-2015\/","title":{"rendered":"IPO Pricings 2.4.2015"},"content":{"rendered":"<p><strong>Thursday Debut<br \/>\n<\/strong><\/p>\n<p><a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/AdvancedAcceleratorApplications-AAAP\">Advanced Accelerator Applications S.A. (Nasdaq: AAAP)<\/a> &#8211;\u00a0\u00a0 The deal <strong>has been postponed<\/strong> due to management&#8217;s decision not to proceed with valuation<\/p>\n<p><a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/AltheaDx-IDGX\" target=\"_blank\">AltheaDx, Inc (Nasdaq: IDGX)<\/a>&#8211;\u00a0\u00a0 The underwriter states that this deal <strong>will now price Thursday night<\/strong> (2\/5) in anticipation of a Friday (2\/6) debut.<\/p>\n<p><a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/AsanteSolutions-PUMP\" target=\"_blank\">Asante Solutions, Inc. (Nasdaq: PUMP)<\/a> &#8211; The underwriter states this deal <strong>did not pric<\/strong>e on Wednesday and \u201cthere is no timing\u201d currently for the deal. The status of this IPO is now considered to be &#8216;Day-to-Day&#8217;.<\/p>\n<p><a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/CarbylanTherapeutics-CBYL\" target=\"_blank\">Carbylan Therapeutics (Nasdaq: CBYL)<\/a> &#8211; The underwriter states that the deal <strong>did not price last night<\/strong>. We are now classifying this IPO as &#8216;Day-to-Day&#8217;. There is no further information at this time.<\/p>\n<p><a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/InotekPharmaceuticals-ITEK\" target=\"_blank\">Inotek Pharmaceuticals Corporation (Nasdaq: ITEK)<\/a> &#8211; The underwriter states that the deal <strong>did not price<\/strong> last night and is to be considered \u2018day-to-day\u2019. There is no further information at this time.<\/p>\n<p><a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/NexvetBiopharma-NVET\" target=\"_blank\">Nexvet Biopharma plc (Nasdaq: NVET)<\/a> &#8211; The deal priced $3.00 below the prevailing $13-$16 range. &#8216;NVET&#8217; priced <strong>4 million shares <\/strong>at<strong> $10.00<\/strong> and will debut on Thursday.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong>IPO Schedule for Remainder of Week<\/strong><\/h2>\n<p><strong>Day to Day<\/strong><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Infraredx-REDX\" target=\"_blank\">Infraredx (Nasdaq: REDX)<\/a><\/p>\n<p><strong>Week of Feb. 2nd<\/strong><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/EyegatePharmaceuticalsInc-EYEG-info.php\" target=\"_blank\">Eyegate Pharmaceuticals (Nasdaq: EYEG)<\/a><\/p>\n<p><strong>Friday<\/strong><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/AltheaDx-IDGX\" target=\"_blank\">AltheaDx, Inc (Nasdaq: IDGX)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Check-CapLtd-CHEK\" target=\"_blank\">Check-Cap Ltd (Nasdaq: CHEK)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/ColumbiaPipelinePartners-CPPL\" target=\"_blank\">Columbia Pipeline Partners LP (NYSE: CPPL)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Easterly%20Government%20Properties-DEA\" target=\"_blank\">Easterly Government Properties (NYSE: DEA)<\/a><\/p>\n<p><em><strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscribe now <\/a><\/strong>to get our full research report, IPO summary and senior managing partner Scott Sweet\u2019s ratings for this week. There are weekly, monthly and annual plans available.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Thursday Debut Advanced Accelerator Applications S.A. (Nasdaq: AAAP) &#8211;\u00a0\u00a0 The deal has been postponed due to management&#8217;s decision not to proceed with valuation AltheaDx, Inc (Nasdaq: IDGX)&#8211;\u00a0\u00a0 The underwriter states that this deal will now price Thursday night (2\/5) in anticipation of a Friday (2\/6) debut. Asante Solutions, Inc. (Nasdaq: PUMP) &#8211; The underwriter states[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,22],"tags":[34,81,100,83,64,82],"class_list":["post-231","post","type-post","status-publish","format-standard","hentry","category-ipo","category-ipo-pricing","tag-aaap","tag-cbyl","tag-idgx","tag-itek","tag-nvet","tag-pump"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=231"}],"version-history":[{"count":12,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/231\/revisions"}],"predecessor-version":[{"id":246,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/231\/revisions\/246"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}